2025-682-E-Health Dept-Pharmalink-Pharmaceutical drug return and destruction services

Browse Search

7 CONFIDENTIAL 11122019 be identified and separated, by the Customer, prior to shipment to PLI. Eligible organizations/covered entities under the 340B Drug Pricing Program must notify PLI of program participation prior to shipment for proper 340B return processing. PLI bears no responsibility in the determination of 340B status without express notification from the Customer. PLI is not responsible for the credit value determination of 340B Goods due to the complexity of contracts and rebates involved. 12. Customer represents and warrants to PLI that all of the Customer’s return Goods hereunder shall comply with all applicable federal, state, and local laws, including without limitation the Prescription Drug Marketing Act (PDMA) and shall meet all other applicable Food and Drug Administration (FDA) requirements and guidelines. 13. Customer represents and warrants to PLI that Customer is the owner of all of the Customer’s Goods and agrees to provide PLI proof of Goods ownership upon request. Failure by to provide such proof shall release PLI from any and all liability related to the disposition of such Goods and the performance of the Services related thereto. 14. PLI shall not be held liable for product value and or service fees when manufacturers or wholesalers become insolvent, file for bankruptcy protection or do not follow the remittance instructions provided them by PLI. 15. PLI reserves the right to dispose of Product PLI believes is not in a creditable state with claim for payment. Disposal fees, including minimum amount due will be invoiced directly to the Customer. 16. Customer will be charged a Future Date Storage Fee and a Handling/Reprocessing Fee as indicated in Section IV. The storage fee will be accrued and invoiced on a monthly basis. The reprocessing fee will be invoiced at the time of reprocessing and product shipment to the Manufacturer. 17. In no event shall PLI be liable for consequential, punitive, special, or other damages except as specifically provided in these Terms and Conditions. 18. Any amounts due PLI may be offset against the balance of the value of any present or future credits. 19. Customer shall pay a product transfer fee to PLI of $1.16/per item if, upon contract termination, Customer requests product stored by PLI be transferred to another reverse distributor or other supply chain entity. Customer shall be responsible for all shipping and freight charges for product transfer. 20. PLI shall make all efforts to expeditiously collect manufacturer and wholesaler credits. Should PLI be required to hire a third-party collection service to collect unsettled credits, the Customer may incur an additional fee, contingent on credit recovery, to offset those collection expenses. 21. PLI shall not be liable for the value of, and cannot guarantee credit for, Goods that were purchased outside of normal distribution channels. This includes Goods that were not purchased directly by the Customer or directly by the Customer from an approved distributor. This also includes Goods that were purchased outside of the United States, as well as counterfeit items. PLI may require proof of purchase and reserves the right to destroy Goods without issuing any credit. PLI shall not be liable to reimburse the Customer or provide payment in any form in the event and to the extent PLI rejects the Customer’s Goods for any reason. 22. Any shipments that result in a leak or spill, as a result of improper packaging from a Customer location may be assessed a $25 spill cleanup fee. 23. Shipments that contain non-inventoried C2 items may be assessed additional compliance fees. Docusign Envelope ID: 550F0A34-DEE8-4FFA-B72D-1ABBE467C60B